Gara Jalqabaatti › Cufama Onnee › Missouri › Kansas City
Qorannoo klinikaalii Cufama Onnee Kansas City, MO keessatti
Qorannoo 25 Cufama Onnee f Kansas City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
ELEVATE-HFpEF Clinical Study
Namoota walitti qabaa jira
- Saint Lukes Mid America Heart Institute, Kansas City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Namoota walitti qabaa jiraSadarkaa 3
- Kansas City VA Medical Center, Kansas City
- North Kansas City Hospital, North Kansas City · Miili 2 fagaatti
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Namoota walitti qabaa jiraSadarkaa 3
- Kansas City VA Medical Center, Kansas City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Kansas City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Namoota walitti qabaa jiraSadarkaa 3
- Saint Luke's Hospital of Kansas City, Kansas City
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Namoota walitti qabaa jira
- Saint Luke's Hospital of Kansas City, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Saint Luke's Hospital of Kansas City, Kansas City
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Namoota walitti qabaa jiraSadarkaa 3
- Kansas City, MO Investigative Site 10002, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Namoota walitti qabaa jiraSadarkaa 3
- CON-10002 Kansas City, MO Investigative Site, Kansas City
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Namoota walitti qabaa jiraQorannoo ilaalaa
- St. Luke's Hospital of Kansas City, Kansas City
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Namoota walitti qabaa jiraSadarkaa 2
- Local Institution - 145, Kansas City
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Namoota walitti qabaa jiraQorannoo ilaalaa
- Kansas City, Kansas City
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Namoota walitti qabaa jiraQorannoo ilaalaa
- St. Luke's Mid-America Heart Institute, Kansas City
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Namoota walitti qabaa jiraSadarkaa 3
- Tenax Investigational Site, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Research Consultants, JCCT Co, Kansas City
Assessment of CCM in HF With Higher Ejection Fraction
Namoota walitti qabaa jira
- St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Namoota walitti qabaa jiraSadarkaa 3
- FIN-10002 Kansas City, MO Investigational Site, Kansas City
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Namoota walitti qabaa jira
- St. Lukes/ Mid-American Heart Institute, Kansas City
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Namoota walitti qabaa jiraSadarkaa 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Namoota walitti qabaa jiraSadarkaa 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Namoota walitti qabaa jira
- St. Luke's Hospital, Kansas City
CCM OPEN HF Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Saint Luke's Hospital Mid America Heart Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Saint Luke's Health System, Kansas City
Qorannoo Cufama Onnee magaalota biroo keessatti
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Dallas, TXQorannoo 42
- Houston, TXQorannoo 36
- Cleveland, OHQorannoo 33
- Chicago, ILQorannoo 31
- Philadelphia, PAQorannoo 31
- San Francisco, CAQorannoo 29
- Durham, NCQorannoo 26
- St. Louis, MOQorannoo 26
- Atlanta, GAQorannoo 25
- Cincinnati, OHQorannoo 24
Qorannoo biroo Kansas City keessatti
- Saree OljooQorannoo 34
- Kansara Qara'a Non-Small CellQorannoo 31
- Saree (Gosoota Hunda)Qorannoo 21
- Dhibee QaraQorannoo 19
- Kansarii ColorectalQorannoo 16
- Kansara MetastatikiiQorannoo 15
- Leukemia Myeloidii HamaaQorannoo 15
- Kansarii ProstateQorannoo 14
- Kansarii OvariiQorannoo 11
- ObesityQorannoo 11
- Sukkaraa Gosa 2Qorannoo 11
- Dhibee Onneessaa fi DhiigaQorannoo 11
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.